ストックスクリーナーアプリを入手
17.74
3.26%
0.56
前日終値:
$17.18
開ける：
$17.31
24時間の取引高:
423.98K
Relative Volume:
0.63
時価総額：
$2.24B
収益：
$628.25M
当期純損益:
$-78.55M
株価収益率:
-23.04
EPS:
-0.77
ネットキャッシュフロー:
$-29.73M
1週間 パフォーマンス:
+15.49%
1か月 パフォーマンス:
+35.73%
6か月 パフォーマンス:
+24.58%
1年 パフォーマンス:
-6.78%
1日の値動き範囲:
$17.31
$17.78
1週間の範囲:
$14.99
$17.78
52週間の値動き範囲:
$12.77
$21.22
Neogenomics Inc Stock (NEO) Company Profile
NEO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
17.74 | 2.24B | 628.25M | -78.55M | -29.73M | -0.77 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
Loomis Sayles & Co. L P Invests $17.81 Million in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
NeoGenomics, Inc. (NASDAQ:NEO) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - Simply Wall St
NeoGenomics, Inc. (NASDAQ:NEO) Stock Holdings Raised by Jennison Associates LLC - MarketBeat
NeoGenomics Inc (NEO) Shares Up 4.09% on Nov 22 - GuruFocus.com
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
NeoGenomics to present new data at AMP 2024 - SelectScience
NeoGenomics, Inc. (NASDAQ:NEO) Q3 2024 Earnings Call Transcript - MSN
NeoGenomics, Inc. (NASDAQ:NEO) Shares Purchased by Segall Bryant & Hamill LLC - MarketBeat
NeoGenomics general counsel sells $79,475 in stock - Investing.com India
NeoGenomics general counsel sells $79,475 in stock By Investing.com - Investing.com UK
NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment - Milton Daily Standard
Los Angeles Capital Management LLC Invests $1.10 Million in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
T. Rowe Price Investment Management Reduces Stake in NeoGenomics Inc - GuruFocus.com
Janus Henderson Group PLC's Strategic Reduction in NeoGenomics I - GuruFocus.com
Felicia Williams Joins NeoGenomics Board of Directors - The Bakersfield Californian
Trend Tracker for (NEO) - Stock Traders Daily
Pathological Examination Market to Grow with Leading Key - openPR
Creative Planning Purchases 7,004 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference - BioSpace
NeoGenomics, Inc. (NASDAQ:NEO) Receives $19.89 Consensus Target Price from Brokerages - Defense World
NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should Know - MSN
NeoGenomics posts $18M net loss in Q3 - Gulfshore Business
Earnings call: NeoGenomics sees growth with NGS and new test launches - Investing.com Canada
NeoGenomics' (NEO) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
NeoGenomics Reports Strong Q3 2024 Growth - TipRanks
NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say - MSN
NeoGenomics receives New York state approval for its solid tumor test - MSN
NeoGenomics: Q3 Earnings Snapshot - The Washington Post
NeoGenomics (NASDAQ:NEO) Updates FY 2024 Earnings Guidance - MarketBeat
NeoGenomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
NeoGenomics Reports Third Quarter 2024 Results - Business Wire
NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to Trade - MSN
Emerald Mutual Fund Advisers Trust Sells 314,330 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
Allspring Global Investments Holdings LLC Reduces Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics (NEO) Set to Announce Quarterly Earnings on Tuesday - Defense World
Blue Trust Inc. Boosts Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics gains conditional approval for solid tumour assays in New York - Medical Device Network
NeoGenomics NGS tests gain New York State approval - Investing.com
NEONeoGenomics, Inc. Latest Stock News & Market Updates - StockTitan
NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test - Business Wire
Clinical Laboratory Tests Market 2023-2031 | Latest Overview Analysis Report - InsightAce Analytic
Truist Financial Corp Sells 4,699 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics (NASDAQ:NEO) Shares Down 2.5%Should You Sell? - MarketBeat
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
1.43%
0.41%
大文字化:
|
ボリューム (24 時間):